Baguio, Chaniel B.
HRN: 27-98-89 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/30/2025
11/05/2025
IV
100mg
Q8
T/C Varicella With Superimposed Bacteria
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes